Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?

Bibliographic Details
Main Author: Assunção, Ricardo
Publication Date: 2021
Other Authors: Twarużek, Magdalena, Kosicki, Robert, Viegas, Carla, Viegas, Susana
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.21/12825
Summary: Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal.
id RCAP_ed78f0c58289cc948b27dbd790893b2b
oai_identifier_str oai:repositorio.ipl.pt:10400.21/12825
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?Green teaMycotoxinPolyphenolsRisk-benefit assessmentEpigallocatechin-3-gallateEGCGIPL/2020/TEAResMyc_ESTeSLUIDB/05608/2020UIDP/05608/2020Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal.MDPIRCIPLAssunção, RicardoTwarużek, MagdalenaKosicki, RobertViegas, CarlaViegas, Susana2021-02-11T17:34:18Z2021-022021-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/12825eng10.3390/toxins13020119info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-12T07:37:36Zoai:repositorio.ipl.pt:10400.21/12825Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:50:42.614895Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
title Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
spellingShingle Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
Assunção, Ricardo
Green tea
Mycotoxin
Polyphenols
Risk-benefit assessment
Epigallocatechin-3-gallate
EGCG
IPL/2020/TEAResMyc_ESTeSL
UIDB/05608/2020
UIDP/05608/2020
title_short Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
title_full Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
title_fullStr Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
title_full_unstemmed Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
title_sort Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
author Assunção, Ricardo
author_facet Assunção, Ricardo
Twarużek, Magdalena
Kosicki, Robert
Viegas, Carla
Viegas, Susana
author_role author
author2 Twarużek, Magdalena
Kosicki, Robert
Viegas, Carla
Viegas, Susana
author2_role author
author
author
author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv Assunção, Ricardo
Twarużek, Magdalena
Kosicki, Robert
Viegas, Carla
Viegas, Susana
dc.subject.por.fl_str_mv Green tea
Mycotoxin
Polyphenols
Risk-benefit assessment
Epigallocatechin-3-gallate
EGCG
IPL/2020/TEAResMyc_ESTeSL
UIDB/05608/2020
UIDP/05608/2020
topic Green tea
Mycotoxin
Polyphenols
Risk-benefit assessment
Epigallocatechin-3-gallate
EGCG
IPL/2020/TEAResMyc_ESTeSL
UIDB/05608/2020
UIDP/05608/2020
description Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-11T17:34:18Z
2021-02
2021-02-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/12825
url http://hdl.handle.net/10400.21/12825
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.3390/toxins13020119
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598355608961024